Technolgies: N-Viro Soil · N-Viro BioDry · N-Viro BioBlend · N-Viro Fuel

Change in Directors or Principal Officers, Financial Statements and Exh
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
(e) NEW EMPLOYMENT AGREEMENT WITH PRINCIPAL EXECUTIVE OFFICER.
Effective February 13, 2007, N-Viro International Corporation (the "Company") entered into a new employment agreement with Timothy R. Kasmoch, the President and Chief Executive Officer of the Company. Mr. Kasmoch has been employed by the Company as the President and Chief Executive Officer since February 14, 2006, and has served as a member of Mr. Kasmoch's prior employment agreement with the Company expired on February 12, 2007. At a meeting of the Board of Directors of the Company on February 15, 2007, the Board re-appointed Mr. Kasmoch as the President and Chief Executive Officer. The new employment agreement was finally approved by the Board of Directors on March 8, 2007.
Mr. Kasmoch's new employment agreement is for a two-year term commencing on February 13, 2007 and provides for automatic renewal of successive one-year terms unless notice is provided ninety (90) days prior to the expiration of the then current term. The agreement provides that Mr. Kasmoch is to receive an annual base salary of $150,000, subject to annual increase at the discretion of the Board. In addition, Mr. Kasmoch is eligible for an annual cash bonus in an amount to be determined, and otherwise subject to the discretion of, the Board. Under the agreement, this determination is to be based upon the Board's complete review of Mr. Kasmoch's performance, including the growth and profitability of the Company.
Generally, the agreement may be terminated by the Company with or without cause or by the Employee for any reason. If the agreement is terminated by the Company without cause (other than by reason of the death or disability of Mr. Kasmoch), Mr. Kasmoch will continue to receive his base salary then in effect for the period between the termination date and the expiration date of the agreement. If the agreement is terminated for any other reason by either party, Mr. Kasmoch is entitled to receive his base salary through the effective date of the termination plus any bonus or incentive compensation which has been earned or payable through the termination date, as provided for in the agreement.
A copy of Mr. Kasmoch's new employment agreement is filed as Exhibit 10.1 to this Current Report.
(e) MATERIAL OPTION GRANT AWARDED TO EXECUTIVE OFFICERS.
On December 30, 2006, the Board approved grants of stock options to certain of the Company's executive officers. Each of the grants, which are exercisable immediately for shares of the Company's common stock, were made pursuant to the 2004 N-Viro International Corporation Stock Option Plan (the "Plan"). The following table sets forth information about the stock option grants:
Number of Shares Exercise Expiration
Name of Officer Title Underlying Options Price Date
------------------ ----------------------- ------------------ --------- ----------
Timothy R. Kasmoch President and CEO 250,000 $ 2.00 12/30/2009
------------------ ----------------------- ------------------ --------- ----------
James K. McHugh Chief Financial Officer 50,000 $ 2.00 12/30/2016
------------------ ----------------------- ------------------ --------- ----------
Howard E. Hartung Chief Operating Officer 10,000 $ 2.00 12/30/2016
------------------ ----------------------- ------------------ --------- ----------
|
The award to each of the officers was based on the recommendation of the Compensation Committee of the Board. The Compensation Committee determined these awards based on a combination of factors, including length of service, contributions to the recent progress of the Company and extraordinary contributions as an employee of the Company. In addition, in the case of Mr. Kasmoch, the Compensation Committee also recognized that Mr. Kasmoch's compensation under his employment agreement was inadequate given his significant contributions to the Company.
In connection with the option grants to Messrs. Kasmoch and McHugh, the Board adopted a waiver of certain provisions of the Plan which would otherwise limit the number of options that any participant may receive. In particular, the Plan provides that a participant may not receive options to purchase more that 25,000 shares of common stock during any calendar year. The Board adopted a limited amendment of these limitations in order to make the grants to Messrs. Kasmoch and McHugh.
Item 9.01 - Financial Statements and Exhibits
(d) Exhibits
Exhibit No. Description
----------- -----------
10.1 Employment Agreement effective as of February 13, 2007.
|